Featured
Skin Cancer Screening
Sugar Editorial Picks
Beauty Byte: Marcia Promotes Skin Cancer Screening
Skin cancer is very prevalent in our society today, so be sure to take advantage of the free skin cancer screening program next month, called Skin Cancer Takes Friends. According to reports, Olay and the American Society for Dermatological Surgery have teamed up with Desperate Housewife, Marcia Cross, to spread awareness of the program, which is meant to encourage people to bring their friends to dermatologic surgeons for a free screening. Look out for Marcia, who will appear in a national print campaign in Shape Magazine and in in-store visuals.
Other Search Results
Free Skin Cancer Screening Coming to a Town Near You
Not to sound too preachy, but sun safety starts with you, no matter your age or complexion. Skin cancer is the most common form of cancer, yet it's also the most preventable and curable form (when detected early). While remembering to apply sunscreen daily is your responsibility, The Skin Cancer Foundation is pitching in with a national tour to keep you in check.
FREE Skin Cancer Screening This Month!
In recognition of Skin Cancer Awareness Month this May, Olay and the American Society for Dermatologic Surgery have joined forces for the third year for "Skin Cancer Takes Friends."
Skin Cancer Takes Friends is a nationwide free skin cancer screening program that encourages everyone to bring their friends to a participating dermasurgeon's office for a free skin cancer screening. What's even better?
Melanoma and other skin cancers
In This Report- Highlights
- Introduction
- Melanoma
- Nonmelanoma Skin Cancer
- Precancerous Skin Condition...
- Causes
- Risk Factors
- Prevention
- Screening
- Diagnosis
- Staging
- Treatment for Melanoma
- Treatment for Nonmelanoma S...
- Prognosis
- Resources
- References
Breast cancer
In This Report- Highlights
- Introduction
- Risk Factors
- Prevention and Lifestyle Fa...
- Symptoms
- Diagnosis
- Prognosis
- Treatment
- Surgery
- Radiation
- Medications
- Chemotherapy
- Hormone Therapy
- Resources
- References
- In September 2007, Evista (raloxifene) was approved for prevention of breast cancer in postmenopausal women with osteoporosis, and postmenopausal women at high risk for invasive breast cancer. Raloxifene and tamoxifen are the only two drugs approved for breast cancer prevention in high-risk women.
- In March 2007, lapatinib (Tykerb) was approved in combination with capecitabine (Xeloda) for treatment of advanced HER2-positive breast cancer.
- In November 2006, trastuzumab (Herceptin) was approved for treatment of early-stage HER2-positive breast cancer. Trastuzumab is also approved for advanced HER2-positive breast cancer.
- The American College of Physicians’ 2007 guidelines recommend that women with a low risk for breast cancer talk to their doctor before starting to have mammogram screening at age 40.
Colon and rectal cancers
In This Report- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Dietary Factors
- Prevention
- Diagnosis
- Staging
- Prognosis
- Surgery
- Medications
- Radiation Treatment
- Follow-up Testing
- Treatment for Metastasized ...
- Resources
- References
Prostate cancer
In This Report- Highlights
- Introduction
- Prognosis
- Risk Factors
- Symptoms
- Conditions with Similar Sym...
- Screening and Diagnosis
- Tests to Determine Severity...
- Treatment
- Treatment Options by Stagin...
- Treatment for Localized Pro...
- Surgery
- Radiation Treatments
- Options if Treatments Fail...
- Other Treatments
- Resources
- References
- Patients should be classified as low, intermediate, or high risk, depending on their PSA levels, cancer stage, and tumor aggressiveness.
- Doctors need to consider patients’ personal preferences and quality of life concerns as well as their clinical status.
- Standard treatment options include active surveillance (watchful waiting), surgery, or radiation therapy. Initial androgen deprivation therapy (hormone therapy) is seldom recommended for localized prostate cancer.
- The American Society of Clinical Oncology (ASCO) 2007 guidelines recommend that doctors delay androgen deprivation therapy for advanced prostate cancer until patients develop symptoms.
Cervical cancer
In This Report- Highlights
- Introduction
- Causes
- Risk Factors
- Prognosis
- Symptoms
- Prevention
- Diagnosis
- Treatment for Cervical Intr...
- Treatment for Cervical Canc...
- Treatment for Invasive Cerv...
- Resources
- References
Non-small cell lung cancer
In This Report- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Lifestyle Changes
- Diagnostic Tests
- Staging Systems
- Surgical Procedures
- Radiation Treatments
- Treatment Options by Stages...
- Chemotherapy Treatments
- Investigative Agents
- Resources
- References
- About 3,000 nonsmokers die each year of lung cancer resulting from exposure to secondhand smoke, according to a 2006 Surgeon General report.
- Advexin, a genetic therapy that contains the p53 tumor-suppressor gene, is showing promise. A 2006 study in Japan found that out of 13 patients with advanced NSCLC receiving Advexin, 10 had stabilized. Advexin is in Phase II clinical trials for NSCLC.
- Studies are finding that NSCLC tumors in people who never smoked have a much higher rate of epithelial growth-factor receptor (EGFR) mutations.
Ovarian cancer
In This Report- Highlights
- Introduction
- Symptoms
- Causes
- Prevention
- Diagnosis
- Prognosis
- Treatment
- Surgery
- Medications
- Radiation Therapy
- Resources
- References
- Bloating
- Pelvic or abdominal pain
- Difficulty eating or feeling full quickly
- Urgent or frequent urination
- Post-menopausal women who use hormone replacement therapy (HRT) for more than 5 years are 20% more likely to develop ovarian cancer than women who do not use HRT, suggests a 2007 study in the Lancet.
More on PopSugar
Holiday
Top Brands
Hanky Panky
Naf Naf
Casual Club